Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants.
Journal: Pediatrics
Published: October 23, 2024
Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: November 09, 2023
Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
Journal: The Journal of infectious diseases
Published: February 07, 2022
Three monthly doses of palivizumab are not adequate for 5-month protection: a population pharmacokinetic analysis.
Journal: Pulmonary pharmacology & therapeutics
Published: July 23, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026